G Medical Innovations Holdings Ltd
GMVDF
$0.0002
$0.000.00%
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 7.86% | 7.86% | -23.97% | -23.97% | -29.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.86% | 7.86% | -23.97% | -23.97% | -29.55% |
| Cost of Revenue | -310.13% | -310.13% | 300.28% | 300.28% | -1.82% |
| Gross Profit | 1,449.18% | 1,449.18% | -530.94% | -530.94% | -69.10% |
| SG&A Expenses | 86.92% | 86.92% | 206.21% | 206.21% | 11.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.98% | 0.98% | 219.71% | 219.71% | 13.21% |
| Operating Income | 1.11% | 1.11% | -386.52% | -386.52% | -38.84% |
| Income Before Tax | 93.19% | 93.19% | -177.93% | -177.93% | -27.19% |
| Income Tax Expenses | 50.00% | 50.00% | 360.00% | 360.00% | 122.22% |
| Earnings from Continuing Operations | 93.16% | 93.16% | -178.50% | -178.50% | -27.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 222.64% | 222.64% | 245.45% | 245.45% | -25.35% |
| Net Income | 94.88% | 94.88% | -177.40% | -177.40% | -27.85% |
| EBIT | 1.11% | 1.11% | -386.52% | -386.52% | -38.84% |
| EBITDA | -2.10% | -2.10% | -463.12% | -463.12% | -45.26% |
| EPS Basic | 97.87% | 97.87% | -42.11% | -42.11% | 17.95% |
| Normalized Basic EPS | 98.32% | 98.32% | -41.47% | -41.47% | -31.22% |
| EPS Diluted | 97.87% | 97.87% | -42.11% | -42.11% | 17.95% |
| Normalized Diluted EPS | 98.32% | 98.32% | -41.47% | -41.47% | -31.22% |
| Average Basic Shares Outstanding | 140.61% | 140.61% | 95.18% | 95.18% | 55.84% |
| Average Diluted Shares Outstanding | 140.61% | 140.61% | 95.18% | 95.18% | 55.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
